Polycythemia vera: Updated Onkopedia Guidelines recommend Interferon alfa as preferred First-line Treatment

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PHASE II TRIAL OF FIRST-LINE SEQUENTIAL TREATMENT WITH INTERLEUKIN-2 PLUS INTERFERON ALFA FOLLOWED BY SORAFENIB IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA
    del Muro, X. Garcia
    Maroto, P.
    Mellado, B.
    Perez, J. L.
    Andres, R.
    Cruz, J.
    Gallardo, E.
    Domenech, M.
    Piulats, J. M.
    ANNALS OF ONCOLOGY, 2008, 19 : 193 - 194
  • [42] Long-term efficacy of first-line versus second-line pegylated interferon in the treatment of essential thrombocythaemia and polycythaemia vera - results of a single-centre retrospective audit
    James, Daniel
    Verigou, Eleni-Anna
    Wilson, Andrew
    O'Nions, Jenny
    Ahmed, Syeda
    Alimam, Samah
    Sekhar, Mallika
    Lambert, Jonathan
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 113 - 113
  • [43] Evaluation of Namibia's antiretroviral therapy guidelines' recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study
    Kalemeera, F.
    Ndevahoma, St
    Mubita, M.
    Godman, Brian
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (06) : 915 - 921
  • [44] Reduction in the prescription of Olanzapine as a first-line treatment for first episode psychosis following the implementation of clinical practice guidelines
    Tony Nguyen
    Seiler, Natalie
    Maguire, James
    Sizer, Holly
    McGorry, Patrick
    Brown, Ellie
    O'Donoghue, Brian
    SCHIZOPHRENIA RESEARCH, 2020, 215 : 469 - 470
  • [45] Updated results of biweekly gemcitabine/nab-paclitaxel as first-line treatment for advanced pancreatic cancer
    Kokkali, S.
    Drizou, M.
    Tripodaki, E.
    Stefanou, D.
    Magou, E.
    Zylis, D.
    Kapiris, M.
    Nasi, D.
    Georganta, C.
    Ardavanis, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [46] Clinical practice guidelines for first-line/after-relapse treatment of patients with follicular lymphoma
    Lopez-Guillermo, Armando
    Caballero, Dolores
    Canales, Miguel
    Provencio, Mariano
    Rueda, Antonio
    Salar, Antonio
    LEUKEMIA & LYMPHOMA, 2011, 52 : 1 - 14
  • [47] Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trial
    Oh, Do-Youn
    Ikeda, Masafumi
    Lee, Choong-kun
    Rojas, Carlos
    Hsu, Chih-Hung
    Kim, Jin Won
    Shen, Lin
    Furuse, Junji
    Park, Joon Oh
    Borad, Mitesh
    de Braud, Filippo
    Bridgewater, John
    Lee, Sunyoung S.
    Moehler, Markus
    Audhuy, Francois
    Osada, Motonobu
    Sato, Masashi
    Yoo, Changhoon
    HEPATOLOGY, 2025, 81 (03) : 823 - 836
  • [48] Variation of allelic load of JAK2 V617F in patients with polycythemia vera and essential thrombocythemia treated in first-line with hydroxyurea
    Marchay, Nathalie
    HEMATOLOGIE, 2011, 17 (02): : 111 - 112
  • [49] Is It Time for Integrase Inhibitors to be the Preferred Regimen for the First-Line Treatment of HIV-1-Infected Naive Patients?
    Yombi, Jean Cyr
    Pozniak, Anton L.
    AIDS REVIEWS, 2016, 18 (02) : 89 - 100
  • [50] Economic evaluation of sunitinib vs. interferon-alfa (IFN-α) in first-line metastatic renal cell carcinoma (mRCC)
    Negrier, S.
    Remak, E.
    Brown, R.
    Kim, S. T.
    Charbonneau, C.
    Motzer, R. J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 303 - 303
12345